Skip to main
SLDB
SLDB logo

Solid Biosciences (SLDB)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Solid Biosciences (SLDB) Stock

About Solid Biosciences (SLDB)

Solid Biosciences, Inc. is a life science company, which engages in the development of treatments for patients with Duchenne muscular dystrophy. It also focuses on developing treatments for neuromuscular and cardiac diseases. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Bennett Arnold, Annie Ganot, and Gilad David Hayeem in March 2013 and is headquartered in Charlestown, MA.
Market cap$349.59M
Today's volume24.9K
Revenue (TTM)
Avg. daily volume1.54M
EBITDA (TTM)-$140.38M
Open$4.41
Price / earnings ratio-1.51x
Today's range$4.36 - $4.67
Debt / equity8.02x
52 week range$2.41 - $10.37
5 year debt / equity9.82x
Beta (LTM)1.74x
Interest coverage-381.55x
Dividend & yield$0.00 (0.00%)
Current ratio10.89x
Ex-dividend date
Next earningsAug 12, 2025
Dividend payable date

Solid Biosciences Stock Rating

What analysts recommend for SLDB stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 33%
Buy 52%
Hold 14%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 15, 2025, the market cap for SLDB stock is $349.6M

The current P/E ratio for SLDB stock is -1.51

The 52-week high for SLDB stock is $10.37. The current SLDB stock price $undefined is 100.00% below its 52-week high

The 52-week low for SLDB stock is $2.41. The current SLDB stock price $undefined has increased 100.00% from its 52-week low

No, the SLDB stock does not pay dividends to its shareholders

The target price for SLDB stock is $18.48 based on the average of what a group of analyst think SLDB stock could be worth at a future date. This is not a prediction by Public.com

How to buy SLDB stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in SLDB stock

    Navigate to the Explore page. Then, type SLDB into the search bar. When you see SLDB stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased SLDB stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Solid Biosciences Stock Earnings

The value each SLDB share was expected to gain vs. the value that each SLDB share actually gained.

Solid Biosciences (SLDB) reported Q1 2025 earnings per share (EPS) of -$0.59, missing estimates of -$0.54 by 9.26%. In the same quarter last year, Solid Biosciences's earnings per share (EPS) was -$0.64. Solid Biosciences is expected to release next earnings on 08/12/2025, with an earnings per share (EPS) estimate of $0.

Buy Solid Biosciences (SLDB) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.